Compare IPCA Labs with AJANTA PHARMA - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

IPCA LABS vs AJANTA PHARMA - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    IPCA LABS AJANTA PHARMA IPCA LABS/
AJANTA PHARMA
 
P/E (TTM) x 23.1 28.8 80.3% View Chart
P/BV x 7.4 6.5 112.4% View Chart
Dividend Yield % 0.2 0.4 56.8%  

Financials

 IPCA LABS   AJANTA PHARMA
EQUITY SHARE DATA
    IPCA LABS
Mar-20
AJANTA PHARMA
Mar-21
IPCA LABS/
AJANTA PHARMA
5-Yr Chart
Click to enlarge
High Rs1,6161,883 85.8%   
Low Rs8441,258 67.1%   
Sales per share (Unadj.) Rs363.2334.0 108.8%  
Earnings per share (Unadj.) Rs48.475.6 64.0%  
Cash flow per share (Unadj.) Rs65.089.0 73.1%  
Dividends per share (Unadj.) Rs5.009.50 52.6%  
Dividend yield (eoy) %0.40.6 67.2%  
Book value per share (Unadj.) Rs286.2346.1 82.7%  
Shares outstanding (eoy) m126.3586.53 146.0%   
Bonus / Rights / Conversions ---  
Price / Sales ratio x3.44.7 72.0%   
Avg P/E ratio x25.420.8 122.3%  
P/CF ratio (eoy) x18.917.7 107.1%  
Price / Book Value ratio x4.34.5 94.7%  
Dividend payout %10.312.6 82.2%   
Avg Mkt Cap Rs m155,407135,898 114.4%   
No. of employees `000NANA-   
Total wages/salary Rs m9,2125,483 168.0%   
Avg. sales/employee Rs ThNMNM-  
Avg. wages/employee Rs ThNMNM-  
Avg. net profit/employee Rs ThNMNM-  
INCOME DATA
Net Sales Rs m45,89428,897 158.8%  
Other income Rs m865260 332.9%   
Total revenues Rs m46,75929,157 160.4%   
Gross profit Rs m8,9059,986 89.2%  
Depreciation Rs m2,1051,161 181.3%   
Interest Rs m19883 239.1%   
Profit before tax Rs m7,4679,002 83.0%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m1,3532,463 54.9%   
Profit after tax Rs m6,1146,539 93.5%  
Gross profit margin %19.434.6 56.1%  
Effective tax rate %18.127.4 66.2%   
Net profit margin %13.322.6 58.9%  
BALANCE SHEET DATA
Current assets Rs m28,55722,178 128.8%   
Current liabilities Rs m13,2648,388 158.1%   
Net working cap to sales %33.347.7 69.8%  
Current ratio x2.22.6 81.4%  
Inventory Days Days3653 67.6%  
Debtors Days Days719 763.3%  
Net fixed assets Rs m24,02118,912 127.0%   
Share capital Rs m253174 145.3%   
"Free" reserves Rs m35,90329,777 120.6%   
Net worth Rs m36,15529,951 120.7%   
Long term debt Rs m1,03016 6,435.6%   
Total assets Rs m52,57841,090 128.0%  
Interest coverage x38.8109.8 35.3%   
Debt to equity ratio x00 5,331.2%  
Sales to assets ratio x0.90.7 124.1%   
Return on assets %12.016.1 74.5%  
Return on equity %16.921.8 77.5%  
Return on capital %20.630.3 68.0%  
Exports to sales %00-   
Imports to sales %00-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m21,43818,097 118.5%   
Fx outflow Rs m9,0222,315 389.8%   
Net fx Rs m12,41515,782 78.7%   
CASH FLOW
From Operations Rs m5,6435,763 97.9%  
From Investments Rs m-5,097-2,824 180.5%  
From Financial Activity Rs m-1,305-3,183 41.0%  
Net Cashflow Rs m-755-244 309.9%  

Share Holding

Indian Promoters % 46.3 70.3 65.8%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 42.9 21.2 202.7%  
FIIs % 17.8 8.9 199.2%  
ADR/GDR % 0.0 0.0 -  
Free float % 53.7 29.7 181.1%  
Shareholders   105,428 45,672 230.8%  
Pledged promoter(s) holding % 0.0 15.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare IPCA LABS With:   UNICHEM LAB  SANDU PHARMA  PIRAMAL ENTERPRISES  ADVANCED ENZYME TECHNOLOGIES  SMS LIFESCIENCES INDIA  



Today's Market

5 Reasons Why Sensex Ended 873 Points Higher Today(Closing)

Indian share markets witnessed positive trading activity throughout the day today and ended on a strong note.

Related Views on News

AJANTA PHARMA Announces Quarterly Results (1QFY22); Net Profit Up 17.6% (Quarterly Result Update)

Jul 31, 2021 | Updated on Jul 31, 2021

For the quarter ended June 2021, AJANTA PHARMA has posted a net profit of Rs 2 bn (up 17.6% YoY). Sales on the other hand came in at Rs 7 bn (up 11.9% YoY). Read on for a complete analysis of AJANTA PHARMA's quarterly results.

AJANTA PHARMA 2020-21 Annual Report Analysis (Annual Result Update)

Jul 8, 2021 | Updated on Jul 8, 2021

Here's an analysis of the annual report of AJANTA PHARMA for 2020-21. It includes a full income statement, balance sheet and cash flow analysis of AJANTA PHARMA. Also includes updates on the valuation of AJANTA PHARMA.

AJANTA PHARMA Announces Quarterly Results (4QFY21); Net Profit Up 23.3% (Quarterly Result Update)

Jul 8, 2021 | Updated on Jul 8, 2021

For the quarter ended March 2021, AJANTA PHARMA has posted a net profit of Rs 2 bn (up 23.3% YoY). Sales on the other hand came in at Rs 8 bn (up 11.0% YoY). Read on for a complete analysis of AJANTA PHARMA's quarterly results.

IPCA LABS Announces Quarterly Results (3QFY21); Net Profit Up 32.2% (Quarterly Result Update)

Feb 5, 2021 | Updated on Feb 5, 2021

For the quarter ended December 2020, IPCA LABS has posted a net profit of Rs 3 bn (up 32.2% YoY). Sales on the other hand came in at Rs 13 bn (up 15.5% YoY). Read on for a complete analysis of IPCA LABS's quarterly results.

AJANTA PHARMA Announces Quarterly Results (3QFY21); Net Profit Up 64.2% (Quarterly Result Update)

Feb 5, 2021 | Updated on Feb 5, 2021

For the quarter ended December 2020, AJANTA PHARMA has posted a net profit of Rs 2 bn (up 64.2% YoY). Sales on the other hand came in at Rs 7 bn (up 15.0% YoY). Read on for a complete analysis of AJANTA PHARMA's quarterly results.

More Views on News

Most Popular

Make Startup Profits from Bluechip Stocks(Profit Hunter)

Jul 21, 2021

A 166-bagger stock can deliver even more gains in this decade.

These Are the Best Stocks to Own(Fast Profits Daily)

Jul 22, 2021

Find out what I think are the best kind on stocks to own in the market.

Cash the Crash in Gas Prices(Fast Profits Daily)

Jul 21, 2021

Get ready to profit from the coming crash in the price of natural gas.

A Trading Hack to Multiply Profits(Fast Profits Daily)

Jul 23, 2021

Use this trading hack and get a big boost in your trading profits.

How to Pick Momentum Stocks(Fast Profits Daily)

Jul 26, 2021

Use my trading momentum strategy to increase your trading profits.

More

Become A Smarter Investor
In Just 5 Minutes

Multibagger Stock Guide 2021
Get our special report Multibagger Stocks Guide (2021 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

IPCA LABS SHARE PRICE


Aug 3, 2021 (Close)

TRACK IPCA LABS

  • Track your investment in IPCA LABS with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

IPCA LABS 8-QTR ANALYSIS

COMPARE IPCA LABS WITH

MARKET STATS